Biogen Q4 Earnings Review: Why I'm Calling Time On This 'Powder Puff' Pharma

If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth . Invest alongside the model portfolio or simply access the investment bank-grade financial models and research. I hope to see you there.Biogen (NASDAQ: BIIB ) reported its Q4 and full-year 2024 earnings on Wednesday, 12th February. I last covered the company for Seeking Alpha after it had announced its Q3 e ...